Literature DB >> 21443195

Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase.

Medhanit Bahta1, George T Lountos, Beverly Dyas, Sung-Eun Kim, Robert G Ulrich, David S Waugh, Terrence R Burke.   

Abstract

Our current study reports the first K(M) optimization of a library of nitrophenylphosphate-containing substrates for generating an inhibitor lead against the Yersinia pestis outer protein phosphatase (YopH). A high activity substrate identified by this method (K(M) = 80 μM) was converted from a substrate into an inhibitor by replacement of its phosphate group with difluoromethylphosphonic acid and by attachment of an aminooxy handle for further structural optimization by oxime ligation. A cocrystal structure of this aminooxy-containing platform in complex with YopH allowed the identification of a conserved water molecule proximal to the aminooxy group that was subsequently employed for the design of furanyl-based oxime derivatives. By this process, a potent (IC(50) = 190 nM) and nonpromiscuous inhibitor was developed with good YopH selectivity relative to a panel of phosphatases. The inhibitor showed significant inhibition of intracellular Y. pestis replication at a noncytotoxic concentration. The current work presents general approaches to PTP inhibitor development that may be useful beyond YopH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443195      PMCID: PMC3085962          DOI: 10.1021/jm200022g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  75 in total

1.  A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

Authors:  Susan L McGovern; Emilia Caselli; Nikolaus Grigorieff; Brian K Shoichet
Journal:  J Med Chem       Date:  2002-04-11       Impact factor: 7.446

2.  Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.

Authors:  Gang Liu; Zhili Xin; Zhonghua Pei; Philip J Hajduk; Cele Abad-Zapatero; Charles W Hutchins; Hongyu Zhao; Thomas H Lubben; Stephen J Ballaron; Deanna L Haasch; Wiweka Kaszubska; Cristina M Rondinone; James M Trevillyan; Michael R Jirousek
Journal:  J Med Chem       Date:  2003-09-25       Impact factor: 7.446

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Overproduction, purification, and biochemical characterization of the dual specificity H1 protein phosphatase encoded by variola major virus.

Authors:  Joseph E Tropea; Jason Phan; David S Waugh
Journal:  Protein Expr Purif       Date:  2006-05-20       Impact factor: 1.650

5.  A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase, YopH.

Authors:  Fa Liu; Ramin Mollaaghababa Hakami; Beverly Dyas; Medhanit Bahta; George T Lountos; David S Waugh; Robert G Ulrich; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2010-03-15       Impact factor: 2.823

6.  High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.

Authors:  Lay Pheng Tan; Hao Wu; Peng-Yu Yang; Karunakaran A Kalesh; Xiaohua Zhang; Mingyu Hu; Rajavel Srinivasan; Shao Q Yao
Journal:  Org Lett       Date:  2009-11-19       Impact factor: 6.005

7.  Uracil-directed ligand tethering: an efficient strategy for uracil DNA glycosylase (UNG) inhibitor development.

Authors:  Yu Lin Jiang; Daniel J Krosky; Lauren Seiple; James T Stivers
Journal:  J Am Chem Soc       Date:  2005-12-14       Impact factor: 15.419

8.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

Authors:  Y A Puius; Y Zhao; M Sullivan; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

9.  Overproduction, purification and structure determination of human dual-specificity phosphatase 14.

Authors:  George T Lountos; Joseph E Tropea; Scott Cherry; David S Waugh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-09-16

10.  Knowledge-based characterization of similarity relationships in the human protein-tyrosine phosphatase family for rational inhibitor design.

Authors:  Dusica Vidović; Stephan C Schürer
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

View more
  16 in total

1.  Structural analysis of human dual-specificity phosphatase 22 complexed with a phosphotyrosine-like substrate.

Authors:  George T Lountos; Scott Cherry; Joseph E Tropea; David S Waugh
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

2.  Oxime-based click chemistry in the development of 3-isoxazolecarboxylic acid containing inhibitors of Yersinia pestis protein tyrosine phosphatase, YopH.

Authors:  Medhanit Bahta; Terrence R Burke
Journal:  ChemMedChem       Date:  2011-06-10       Impact factor: 3.466

3.  Oxime-based linker libraries as a general approach for the rapid generation and screening of multidentate inhibitors.

Authors:  Medhanit Bahta; Fa Liu; Sung-Eun Kim; Andrew G Stephen; Robert J Fisher; Terrence R Burke
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

Review 4.  Small molecule tools for functional interrogation of protein tyrosine phosphatases.

Authors:  Rongjun He; Li-Fan Zeng; Yantao He; Sheng Zhang; Zhong-Yin Zhang
Journal:  FEBS J       Date:  2012-08-16       Impact factor: 5.542

5.  Structure-guided studies of the SHP-1/JAK1 interaction provide new insights into phosphatase catalytic domain substrate recognition.

Authors:  Nilda L Alicea-Velázquez; Jean Jakoncic; Titus J Boggon
Journal:  J Struct Biol       Date:  2013-01-04       Impact factor: 2.867

6.  Inhibitors of the Yersinia protein tyrosine phosphatase through high throughput and virtual screening approaches.

Authors:  Xin Hu; Milos Vujanac; Noel Southall; C Erec Stebbins
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

7.  High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design.

Authors:  George T Lountos; Sreejith Raran-Kurussi; Bryan M Zhao; Beverly K Dyas; Terrence R Burke; Robert G Ulrich; David S Waugh
Journal:  Acta Crystallogr D Struct Biol       Date:  2018-10-02       Impact factor: 7.652

8.  Biomolecular Interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase.

Authors:  Megan Hogan; Medhanit Bahta; Scott Cherry; George T Lountos; Joseph E Tropea; Bryan M Zhao; Terrence R Burke; David S Waugh; Robert G Ulrich
Journal:  Chem Biol Drug Des       Date:  2013-03       Impact factor: 2.817

9.  X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.

Authors:  Michael R Witten; Lisa Wissler; Melanie Snow; Stefan Geschwindner; Jon A Read; Nicholas J Brandon; Angus C Nairn; Paul J Lombroso; Helena Käck; Jonathan A Ellman
Journal:  J Med Chem       Date:  2017-11-08       Impact factor: 7.446

10.  Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.

Authors:  Katie R Martin; Pooja Narang; José L Medina-Franco; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  Methods       Date:  2013-08-20       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.